C Ronald Kahn Selected Research

Inflammation (Inflammations)

1/2021	Altered pattern of circulating miRNAs in HIV lipodystrophy perturbs key adipose differentiation and inflammation pathways.
11/2020	Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance.
1/2020	Fructose and hepatic insulin resistance.
1/2020	Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
12/2018	Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.
12/2016	Antibiotic effects on gut microbiota and metabolism are host dependent.
1/2013	Absence of diabetes and pancreatic exocrine dysfunction in a transgenic model of carboxyl-ester lipase-MODY (maturity-onset diabetes of the young).
10/2011	The differential role of Hif1β/Arnt and the hypoxic response in adipose function, fibrosis, and inflammation.
1/2011	Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism.
5/2010	Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Ronald Kahn Research Topics

Disease

100	Insulin Resistance 01/2022 - 01/2002
43	Obesity 01/2022 - 04/2002
35	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2003
17	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 07/2004
17	Glucose Intolerance 10/2021 - 07/2002
17	Hyperinsulinism (Hyperinsulinemia) 01/2021 - 12/2002
11	Inflammation (Inflammations) 01/2021 - 06/2004
10	Hyperglycemia 02/2014 - 12/2002
8	Weight Gain 01/2021 - 11/2007
8	Lipodystrophy 01/2021 - 02/2004
7	Hyperplasia 01/2019 - 10/2003
7	Body Weight (Weight, Body) 01/2019 - 07/2002
7	Fatty Liver 11/2017 - 02/2004
6	Neoplasms (Cancer) 11/2012 - 04/2002
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 04/2010
5	Hypoglycemia (Reactive Hypoglycemia) 05/2015 - 01/2002
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 11/2013
4	Fibrosis (Cirrhosis) 01/2021 - 10/2011
4	Liver Diseases (Liver Disease) 12/2020 - 08/2007
4	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
4	Metabolic Diseases (Metabolic Disease) 01/2017 - 02/2008
4	Alzheimer Disease (Alzheimer's Disease) 10/2015 - 03/2004
3	Cardiomegaly (Heart Hypertrophy) 01/2021 - 12/2007
3	Hypertriglyceridemia 01/2021 - 07/2004
3	Hypertrophy 01/2019 - 12/2007
3	Carcinogenesis 01/2019 - 06/2010
3	Muscular Atrophy (Muscle Atrophy) 01/2019 - 06/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2015 - 03/2004
3	Hypoxia (Hypoxemia) 06/2010 - 08/2003
3	Heart Failure 05/2010 - 03/2007
2	SHORT syndrome 01/2017 - 07/2013
2	Wounds and Injuries (Trauma) 07/2015 - 05/2012
2	Exocrine Pancreatic Insufficiency 01/2013 - 01/2010
2	Hypercholesterolemia 04/2012 - 05/2005
2	Abdominal Obesity 04/2012 - 08/2007
2	Ketosis 12/2011 - 01/2003

Drug/Important Bio-Agent (IBA)

103	Insulin (Novolin)FDA Link 06/2022 - 01/2002
53	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2002
46	Insulin ReceptorIBA 10/2021 - 07/2002
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
13	LipidsIBA 01/2021 - 08/2007
11	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019 - 06/2003
10	LeptinIBA 01/2017 - 04/2002
9	Phosphotransferases (Kinase)IBA 01/2021 - 02/2005
8	Triglycerides (Triacylglycerol)IBA 07/2011 - 07/2002
7	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2014
7	EnzymesIBA 01/2020 - 07/2003
6	CholesterolIBA 01/2021 - 07/2008
6	Messenger RNA (mRNA)IBA 01/2019 - 03/2003
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 07/2004
5	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 09/2003
5	Transcription Factors (Transcription Factor)IBA 01/2019 - 10/2004
5	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017 - 01/2002
5	CytokinesIBA 01/2016 - 06/2004
5	Insulin-Like PeptidesIBA 01/2016 - 03/2007
5	PPAR gammaIBA 05/2009 - 03/2003
4	Insulin Receptor Substrate ProteinsIBA 01/2020 - 06/2003
4	FructoseIBA 01/2020 - 05/2016
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016 - 04/2009
4	Tyrosine (L-Tyrosine)FDA Link 01/2009 - 06/2004
4	Sterol Regulatory Element Binding Protein 1IBA 07/2006 - 07/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2010
3	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2016
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2021 - 03/2002
3	Amino Acids FDA Link 01/2021 - 02/2005
3	AdiponectinIBA 01/2021 - 11/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 12/2007
3	Hypoglycemic Agents (Hypoglycemics)IBA 10/2017 - 08/2003
3	Hormones (Hormone)IBA 02/2014 - 11/2005
3	AntioxidantsIBA 11/2013 - 04/2002
3	Sirtuin 3IBA 10/2011 - 02/2011
3	Stearoyl-CoA DesaturaseIBA 10/2011 - 05/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 08/2003
3	Suppressor of Cytokine Signaling ProteinsIBA 10/2005 - 06/2004
2	Amylases FDA Link 01/2022 - 01/2013
2	Vancomycin FDA LinkGeneric 01/2022 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2006
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2019
2	LipofuscinIBA 12/2020 - 01/2020
2	ketohexokinaseIBA 01/2020 - 11/2017
2	Liver GlycogenIBA 01/2020 - 12/2005
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2020 - 08/2007
2	Dietary SugarsIBA 01/2020 - 10/2019
2	Protein Isoforms (Isoforms)IBA 01/2019 - 04/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 12/2016
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2017 - 06/2007
2	CorticosteroneIBA 07/2017 - 05/2005
2	Arginine (L-Arginine)FDA Link 01/2017 - 02/2005
2	Bile Acids and Salts (Bile Acids)IBA 12/2016 - 07/2008
2	Dietary Fats (Dietary Fat)IBA 05/2016 - 05/2005
2	AdipokinesIBA 01/2016 - 04/2004
2	Protein Kinase CIBA 12/2015 - 04/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 08/2011
2	Streptozocin (Streptozotocin)FDA Link 02/2015 - 09/2004
2	CarbohydratesIBA 02/2014 - 04/2012
2	Lipase (Acid Lipase)FDA Link 01/2013 - 01/2010
2	EstersIBA 01/2013 - 01/2010
2	GlucocorticoidsIBA 11/2012 - 12/2007

Therapy/Procedure

9	Therapeutics 01/2022 - 08/2002
3	Caloric Restriction 09/2012 - 12/2007